NCT01542632View on ClinicalTrials.gov

A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

January 1, 2014

Study Completion Date

January 10, 2014

Conditions
Healthy
Interventions
BIOLOGICAL

Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

TDV subcutaneous injection

BIOLOGICAL

TDV New Formulation

TDV New Formulation subcutaneous injection

DRUG

Placebo

Placebo subcutaneous injection

DRUG

New Formulation Placebo

New Formulation placebo subcutaneous injection

Trial Locations (3)

77555

University of Texas Medical Branch, Galveston

80528

Heart Center of the Rockies, Fort Collins

84088

Advanced Clinical Research, West Jordan

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01542632 - A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter